The use of individual patient-level data (IPD) to quantify the impact of pretreatment predictors of response to treatment in chronic hepatitis B patients

OBJECTIVES: Evidence synthesis is an integral part decision-making by reimbursement agencies. When direct evidence is not available, network-meta-analysis (NMA) techniques are commonly used. This approach assumes that the trials are sufficiently similar in terms of treatment-effect modifiers. When i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Shehzad, Mealing, Stuart, Hawkins, Neil, Lescrauwaet, Benedicte, Bjork, Stefan, Mantovani, Lorenzo, Lampertico, Pietro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563125/
https://www.ncbi.nlm.nih.gov/pubmed/23355658
http://dx.doi.org/10.1136/bmjopen-2012-001309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563125/
https://www.ncbi.nlm.nih.gov/pubmed/23355658
http://dx.doi.org/10.1136/bmjopen-2012-001309

Ejemplares similares